Clinical ResearchImpact of Access Site on Bleeding and Ischemic Events in Patients With Non–ST-Segment Elevation Myocardial Infarction Treated With Prasugrel: The ACCOAST Access Substudy
Key Words
Abbreviations and Acronyms
Cited by (0)
This trial was sponsored by Daiichi-Sankyo Company, Ltd., and Eli Lilly and Co. The coordinating center was the ACTION Study Group, Institute of Cardiology of Pitié-Salpêtrière Hospital. ACCOAST trial data from the primary study were collected, managed, and analyzed by a clinical research organization contracted by the sponsors according to the protocol and a pre-defined statistical analysis plan. Dr. Porto has received consulting and lecture fees from AstraZeneca, Boston Scientific, St. Jude Medical, Terumo, and Volcano. Dr. Bolognese has received fees for board membership from Daiichi-Sankyo and Eli Lilly; consulting fees from Daiichi-Sankyo; and lecture fees from Daiichi-Sankyo, Eli Lilly, Menarini, Abbott, AstraZeneca, and Iroko Cardio International. Dr. Dudek has received consulting and lecture fees from Abbott, Adamed, Adyton Medical Polska, Abiomed Europe, AstraZeneca, Biotronik, Balton, Bayer, Braun, BioMatrix, Boston Scientific, Boehringer Ingelheim, Bracco, Bristol-Myers Squibb, Comesa Polska, Cordis, Cook, Covidien Polska, DRG MedTek, Eli Lilly, EuroCor, Hammermed, GE Healthcare, GlaxoSmithKline, Inspire-MD, Iroko Cardio International, Medianet, Medtronic, The Medicines Company, Meril Life Sciences, Merck Sharp & Dohme, Orbus-Neich, Pfizer, Possis, ProCardia Medical, Promed, REVA Medical, Sanofi, Siemens, Solvay, Stentys, St. Jude Medical, Terumo, Tyco, and Volcano. Dr. Goldstein has received fees for board membership from Boehringer Ingelheim, The Medicines Company, Daiichi-Sankyo, and Eli Lilly; consulting fees from Boehringer Ingelheim, Bayer, Sanofi, and AstraZeneca; lecture fees from Boehringer Ingelheim, The Medicines Company, Daiichi-Sankyo, Bayer, Sanofi, AstraZeneca, and Eli Lilly; payment for the development of educational presentations from Boehringer Ingleheim and AstraZeneca; and travel support from AstraZeneca, Bayer, Boehringer Ingelheim, Daiichi-Sankyo, The Medicines Company, and Sanofi. Dr. Hamm has received payment for board membership from AstraZeneca, Medtronic, and Boehringer Ingelheim; consulting and lecture fees from Medtronic, Boehringer Ingelheim, Eli Lilly, The Medicines Company, Abbott Vascular, Bayer, Sanofi, Boston Scientific, Correvio, Roche Diagnostics, Pfizer, Cordis, Daiichi-Sankyo, and GlaxoSmithKline; and lecture fees from AstraZeneca and Merck. Dr. Tanguay has received consulting fees from Eli Lilly, AstraZeneca, Abbott Vascular, Roche, and GlaxoSmithKline; lecture fees from Bayer, Sanofi, Eli Lilly, AstraZeneca, Abbott Vascular, Pfizer, and Bristol-Myers Squibb; and grant support from Eli Lilly, AstraZeneca, Roche, Hexacath, Ikaria, Abbott Vascular, GlaxoSmithKline, Roche, and Sanofi. Dr. ten Berg has received fees for board membership from AstraZeneca; consulting fees from AstraZeneca, Eli Lilly, and Merck; and lecture fees from AstraZeneca, Eli Lilly, and The Medicines Company. Dr. Widimsky has received consulting and lecture fees from Eli Lilly and Daiichi-Sankyo. Mr. Le Gall is an employee of inVentiv Health Company, whose work is funded by Eli Lilly. Mr. Zagar, Dr. LeNarz, and Ms. Miller are employees and shareholders of Eli Lilly and Company. Dr. Montalescot has received consulting fees from Bayer, Boehringer Ingelheim, Cardiovascular Research Foundation, Europa Organisation, the Gerson Lehrman Group, Iroko Cardio International, Lead-Up, Luminex, McKinsey & Company, Inc., Remedica, Servier, TIMI Study Group, WebMD, Wolters Kluwer Health, Bristol-Myers Squibb, AstraZeneca, Biotronik, Eli Lilly, The Medicines Company, Menarini Group, Roche, Sanofi, Pfizer, Daiichi-Sankyo, and Medtronic; and grant support from Bristol-Myers Squibb, AstraZeneca, Biotronik, Eli Lilly, The Medicines Company, Menarini Group, Sanofi, Pfizer, Roche, Accumetrics, Medtronic, Abbott Laboratories, Daiichi-Sankyo, Nanosphere Inc., and Stentys.